EUVIMEDEUVIMED entdecken
Fallbericht

De novo osteosarcoma following prolonged denosumab treatment for giant cell tumor of bone at an anatomically distant site: a case report

Katherine Elon Burbank, Robert Mikael Henshaw, James Stephen Jelinek, Mark D Murphey

Skeletal Radiology · 2026-12 · 55 (12) · 3389-3396

DOI: 10.1007/s00256-026-05347-4 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Skeletal Radiology, online erschienen am 29.08.2026. Verfasst von Katherine Elon Burbank und 3 weiteren Autor:innen. Beteiligte Einrichtung: Georgetown University School of Medicine, 3900 Reservoir Rd NW, Washington, DC, 20007, USA. keb320@georgetown.edu. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Bone Neoplasms, Denosumab, Giant Cell Tumor of Bone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Denosumab is a monoclonal antibody targeting RANKL, FDA-approved for the treatment of giant cell tumor of bone (GCTB). While it has shown efficacy in tumor regression and bone preservation, rare cases of malignant transformation to osteosarcoma have been associated with denosumab treatments. Previous literature has attributed such cases to either initial misdiagnosis of a malignant giant cell tumor at baseline presentation or, more rarely, transformation of previously histologically benign GCTB to a secondary malignant GCTB. To our knowledge, these cases involved or arose from an existing giant cell tumor neoplasm. We present a unique case of a patient who developed de novo osteosarcoma at a distant location from their original GCTB tumor following prolonged denosumab therapy, highlighting the clinical course, diagnostic challenges, and therapeutic considerations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Density Conservation AgentsBone NeoplasmsDenosumabGiant Cell Tumor of BoneOsteosarcomaFemaleHumansMaleDiagnosis, DifferentialMagnetic Resonance ImagingTomography, X-Ray Computed

Stichwörter der Autor:innen

DenosumabGiant cell tumor of boneOsteosarcomaSarcoma

Substanzen

Bone Density Conservation AgentsDenosumab

Autor:innen und Institutionen

  • Georgetown University School of Medicine, 3900 Reservoir Rd NW, Washington, DC, 20007, USA. keb320@georgetown.edu.
  • Division of Orthopedic Oncology, Medstar Georgetown Orthopedics Institute, Washington, DC, USA.
  • MedStar Medical Group Radiology, MedStar Washington Hospital Center, 110 Irving St., NW, Washington, DC, 20010, USA.
  • Uniformed Services University of the Health Sciences, American Institute for Radiologic Pathology, 8901 Wisconsin Ave, Bethesda, MD, 20889, USA.

Zitieren

APA

Burbank, K. E., Henshaw, R. M., Jelinek, J. S., & Murphey, M. D. (2026). De novo osteosarcoma following prolonged denosumab treatment for giant cell tumor of bone at an anatomically distant site: a case report. Skeletal Radiology, 55(12), 3389-3396. https://doi.org/10.1007/s00256-026-05347-4

Vancouver

Burbank KE, Henshaw RM, Jelinek JS, Murphey MD. De novo osteosarcoma following prolonged denosumab treatment for giant cell tumor of bone at an anatomically distant site: a case report. Skeletal Radiology. 2026;55(12):3389-3396. doi:10.1007/s00256-026-05347-4

BibTeX
@article{Burbank2026,
  author = {Burbank, Katherine Elon and Henshaw, Robert Mikael and Jelinek, James Stephen and Murphey, Mark D},
  title = {De novo osteosarcoma following prolonged denosumab treatment for giant cell tumor of bone at an anatomically distant site: a case report},
  journal = {Skeletal Radiology},
  year = {2026},
  volume = {55},
  number = {12},
  pages = {3389--3396},
  doi = {10.1007/s00256-026-05347-4}
}
Kostenlos starten →